Correlation Between Woori Financial and CASI Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Woori Financial and CASI Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Woori Financial and CASI Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Woori Financial Group and CASI Pharmaceuticals, you can compare the effects of market volatilities on Woori Financial and CASI Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Woori Financial with a short position of CASI Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Woori Financial and CASI Pharmaceuticals.

Diversification Opportunities for Woori Financial and CASI Pharmaceuticals

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Woori and CASI is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Woori Financial Group and CASI Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CASI Pharmaceuticals and Woori Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Woori Financial Group are associated (or correlated) with CASI Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CASI Pharmaceuticals has no effect on the direction of Woori Financial i.e., Woori Financial and CASI Pharmaceuticals go up and down completely randomly.

Pair Corralation between Woori Financial and CASI Pharmaceuticals

Allowing for the 90-day total investment horizon Woori Financial Group is expected to generate 0.36 times more return on investment than CASI Pharmaceuticals. However, Woori Financial Group is 2.8 times less risky than CASI Pharmaceuticals. It trades about 0.23 of its potential returns per unit of risk. CASI Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest  3,772  in Woori Financial Group on May 5, 2025 and sell it today you would earn a total of  1,371  from holding Woori Financial Group or generate 36.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Woori Financial Group  vs.  CASI Pharmaceuticals

 Performance 
       Timeline  
Woori Financial Group 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Woori Financial Group are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating technical and fundamental indicators, Woori Financial reported solid returns over the last few months and may actually be approaching a breakup point.
CASI Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days CASI Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in September 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Woori Financial and CASI Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Woori Financial and CASI Pharmaceuticals

The main advantage of trading using opposite Woori Financial and CASI Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Woori Financial position performs unexpectedly, CASI Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CASI Pharmaceuticals will offset losses from the drop in CASI Pharmaceuticals' long position.
The idea behind Woori Financial Group and CASI Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
CEOs Directory
Screen CEOs from public companies around the world